TP53 and central nervous system cancer: Thus, we performed GSEA on the differential expression analysis comparing the transformed glioma cells in the vehicle- and RSL3-treated slices using mitochondrial metabolic signatures that were enriched in the N1IC model relative to the p53 model (Figs. 7J and 2B).